Pembrolizumab-induced sarcoidal infusion site reaction
J Cutan Pathol
.
2018 Jun 25.
doi: 10.1111/cup.13307.
Online ahead of print.
Authors
Robert J Smith
1
,
Tara C Mitchell
2
,
Emily Y Chu
1
Affiliations
1
Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
2
Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
PMID:
29938827
DOI:
10.1111/cup.13307
No abstract available
Keywords:
PD-1 inhibitor; immune-related adverse events; pembrolizumab; sarcoidosis.